Horm Metab Res 2006; 38(12): 783-788
DOI: 10.1055/s-2006-956506
Original Basic

© Georg Thieme Verlag KG Stuttgart · New York

Ghrelin Ovarian Cell Expression in Patients with Polycystic Ovary Syndrome: An Immunohistochemical Evaluation

H. Komarowska 1 , R. Waśko 1 , K. Iwanik 2 , P. Majewski 2 , L. Rafińska 3 , A. Warenik-Szymankiewicz 4 , J. Sowiński 1
  • 1Department of Endocrinology, Metabolism and Internal Medicine, Poznań University of Medical Sciences, Poznań, Poland
  • 2Department of Pathomorphology, Poznań University of Medical Sciences
  • 3Department of Histology and Embryology, Poznań University of Medical Sciences, Poznań, Poland
  • 4Department of Gynecological Endocrinology, Poznań University of Medical Sciences, Poznań, Poland
Further Information

Publication History

Received 27 September 2005

Accepted after second revision 7 March 2006

Publication Date:
12 December 2006 (online)

Abstract

Introduction: The influence of ghrelin on different organs has been studied recently, e.g. in the regulation of pituitary hormone release, regulation of energy homeostasis, glucose metabolism and insulin secretion, cell proliferation, and reproductive function. However, the etiology of polycystic ovary syndrome has not been fully explained. The aim of our study was to estimate the presence of ghrelin in polycystic ovaries cells and evaluation of the relationship between ghrelin occurrence and cells proliferation. Methods: In the present work we have compared ten polycystic ovaries with ovaries without pathology as the control group. We used immunohistochemical method to detect ghrelin. The cells proliferation was evaluated by Ki 67 proliferation index. Results: Ghrelin immunostaining was demonstrated in cytoplasm of ovarian secondary interstitial cells and in atretic corpus luteum. The cell nuclei were ghrelin positive in granulosa, theca layers of follicular cyst in both groups as well as in luteal cells of young corpus luteum in healthy ovaries. Ki 67 immunostaining was observed in granulosa and theca layers of follicular cyst in polycystic and healthy ovaries. Conclusions: It is possible that local ghrelin expression plays an important role in the direct control of ovarian development and function and ghrelin may participate in patomechanism of PCOS.

References

  • 1 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach.  Nature. 1999;  402 656-660
  • 2 Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma T, Matsukura S, Kangawa K, Nakazato M. Ghrelin, a novel growth hormone acyclated peptide, is synthesized in the gastrointestinal tract of rats and humans.  Endocrinol. 2000;  141 4255-4261
  • 3 Kagotani Y, Sakata I, Yamazaki M, Nakamura K, Hayashi Y, Kangawa K. Localization of ghrelin-immunopositive cells in the rat hypothalamus and intestinal tract. Proceedings of the 83rd Annual Meeting of the Endocrine Society Denver, Co.  2001;  337
  • 4 Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.  Horm Metab Res. 2003;  35 455-459
  • 5 Korbonits M, Kojima M, Kangawa K, Grossman AB. Presence of ghrelin in normal and adenomatous human pituitary.  Endocrine. 2001;  14 101-104
  • 6 Gualillo O, Caminos J, Blanco M, Garcia-Caballero T, Kojima M, Kangawa K, Dieguez C, Casanueva FF. Ghrelin, a novel placental-derived hormone.  Endocrinol. 2001;  142 788-794
  • 7 Gnanapavan S, Kola B, Bustin SA, Morris DG, McGee P, Fairclough P, Bhattacharaya S, Carpenter R, Grossman AB, Korbonits M. The tissue distribution of the m RNA of ghrelin and subtypes of its receptor, GHS-R, in humans.  J Clin Endocrinol Metab. 2002;  87 2988-2991
  • 8 Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S. Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion.  Diabetes. 2002;  51 124-129
  • 9 Volante M, Allia E, Gugliotta P, Funaro A, Broglio F, Deghenghi R, Muccioli G, Ghigo E, Papotti M. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors.  J Clin Endocrinol Metab. 2002;  87 1300-1308
  • 10 Tena-Sempere M, Barreiro ML, Gonzales LC, Gaytan F, Zhang FP, Camios JE, Pinilla L, Casanueva FF, Dieguez C, Aguilar E. Novel expression and functional role of ghrelin in rat testis.  Endocrinol. 2002;  143 717-725
  • 11 Barreiro ML, Gaytán F, Caminos JE, Pinilla L, Casanueva FF, Aguilar E, Diéguez C, Tena-Sempere M. Cellular location and hormonal regulation of ghrelin expression in rat testis.  Biol Reprod. 2002;  67 1768-1776
  • 12 Caminos JE, Tena-Sampere M, Gaytan F, Sanchez-Criado JE, Barreiro ML, Nogueiras R, Casanueva FF, Aguilar E, Dieguez C. Expression of ghrelin in the cyclic and pregnant rat ovary.  Endocrinol. 2003;  144 1594-1602
  • 13 Gaytan F, Barreiro ML, Chopin LK, Herington AC, Morales C, Pinilla L, Casanueva FF, Aguilar E, Dieguez C, Tena-Sampere M. Immunolocalization of ghrelin and its functional receptor, the Type 1A growth hormone secretagogue receptor in the cyclic human ovary.  J Clin Endocrinol Metab. 2003;  88 879-887
  • 14 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S. A role for ghrelin in the central regulation of feeding.  Nature. 2001;  409 194-198
  • 15 Cowley MA. et al . The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis.  Neuron. 2003;  37 649-661
  • 16 Horvath TL, Diano S, Sotonyi P, Heiman ML, Tschop M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective.  Endocrinol. 2001;  142 4163-4168
  • 17 Pagotto U, Gambineri A, Pelusi C, Genghini S, Cacciaru M, Otto B, Castaneda B, Tschöp M, Pasquali R. Testosterone replacement therapy restores normal ghrelin in hypogonadal men.  J Clin Endocrinol Metab. 2003;  88 4139-4143
  • 18 Pagotto U, Gambineri A, Vicennati V, Heiman ML, Tschöp M, Pasquali R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels.  J Clin Endocrinol Metab. 2002;  87 5625-5629
  • 19 Waśko R, Komarowska H, Warenik-Szymankiewicz A, Sowiński J. Elevated ghrelin plasma levels in patients with polycystic ovary syndrome.  Horm Metab Res. 2004;  36 170-173
  • 20 Schõfl Ch, Rûdiger H, Schill T, Schlösser HW, Mûller MJ, Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2002;  87 4607-4610
  • 21 Orio Jr F, Lucidi P, Palomba S, Tauchmanova L, Cascella T, Russo T, Zullo F, Colao A, Lombardi G, De Feo P. Circulating ghrelin concentrations in polycystic ovary syndrome.  J Clin Endocrinol Metab. 2003;  88 942-945
  • 22 Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C. et al . A receptor in pituitary and hypothalamus that functions in growth hormone release.  Science. 1996;  273 974-977
  • 23 Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots L, Azziz R. Prevalence of the polycistic ovary syndrome in unselected black and white women of the southestern United States: prospective study.  J Clin Endocrinol Metab. 1998;  83 3078-3082
  • 24 Franks S. Polycystic ovary syndrome.  N Engl J Med. 1995;  333 853-861
  • 25 Solomon CG. The epidemiology of polycystic ovary syndrome. Prevalence and associated disease risks.  Endocrinol Metab Clin North Am. 1999;  28 247-263
  • 26 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.  Fertil Steril. 2004;  81 19-25
  • 27 Casanueva FF, Dieguez C. Endocrine regulation and actions of leptin.  Frot Neuroendocrinol. 1999;  20 317-363
  • 28 Govoni N, Galeati G, Castellani G, Tamanini. Leptin concentration in plasma and follicular fluid from prepubertal gilts as influenced by fasting, refeeding and insulin.  Horm Metab Res. 2005;  37 152-158
  • 29 , Skałba Piotr: Endokrynologia ginekologiczna, wyd.II,: rozdział 3, 44; PZWL 2003; 
  • 30 Volante M, Allia E, Fulcheri E, Cassoni P, Ghigo E, Muccioli G, Papotti M. Ghrelin in fetal thyroid and follicular tumors and cell lines expression and effects on tumor growth.  Am J Pathol. 2003;  162 645-654
  • 31 Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, Graziani A, Deghenghi R, Reissmann T, Ghigo E. Identification, characterization and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues in human breast carcinomas and cell lines.  J Clin Endocrinol Metab. 2001;  86 1738-1745
  • 32 Broglio F, Gottero C, Prodam FC, Muccioli G, Papotti M, Abribat T, Van der Lely AJ, Ghigo E. Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in human.  J Clin Endocrinol Metab. 2004;  89 3062-3065
  • 33 Andreis PG, Malendowicz LK, Trejter M, Neri G, Spinazzi R, Rossi GP, Nussdorfer GG. Ghrelin and growth hormone secretagogue receptor are expressed in the rat adrenal cortex: evidence that ghrelin stimulates the growth, but not the secretory activity of adrenal cells.  FEBS Lett. 2003;  11,536 173-179
  • 34 Zhang W, Zhao L, Lin TR, Chai B, Fan Y, Gantz I, Mulholland MW. Inhibition of Adipogenesis by Ghrelin Mol Biol Cell.  2004;  15 2484-2491
  • 35 Zhang W, Lin TR, Hu Y, Fan Y, Zhao L, Stuenkel EL, Mulholland MW. Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus.  J Physiol. 2004;  559 729-737
  • 36 Pettersson I, Muccioli G, Granata R, Deghenghi R, Ghigo E, Ohlsson C, Isgaard J. Natural (ghrelin) and synthetic (hexarelin) GH secretagogues stimulate H9c2 cardiomyocyte cell proliferation.  J Endocrinol. 2002;  175 201-209
  • 37 Barreiro ML, Gaytan F, Castellano JM, Suominen JS, Roa J, Gaytan M, Aguilar E, Dieguez C, Toppari J, Tena-Sempere M. Ghrelin inhibits the proliferative activity of immature leydig cells in vivo and regulates stem cell factor messenger ribonucleic acid expression in rat testis.  Endocrinol. 2004;  145 4825-4834
  • 38 Takayama K, Fukaya T, Sasano H, Funayma Y, Takashi S, Takaya R, Wada Y, Yajima A. Immunohistochemical study of steroidogenesis and cell proliferation in polycystic ovarian syndrome.  Hum Reprod. 1996;  11 1387-1392
  • 39 Yen SSC. The polycystic ovary.  Clinical Endocrinilogy. 1980;  12 177-208
  • 40 Maciel GA, Baracat EC, Benda JA, Markham SM, Hensinger K, Chang RJ, Erickson GF. Stockpiling of transitional and classic primary follicles in ovaries of women with polycystic ovary syndrome.  J Clin Endocrinol Metab. 2004;  89 5321-5327

Correspondence

Hanna Komarowska M.D.,Ph.D 

Department of Endocrinology

Metabolism and Internal Medicine

Poznań University of Medical Sciences

ul. Przybyszewskiego 49

60-355 Poznań

Poland

Phone: +48/61/869/13 30

Fax: +48/61/869/16 82

Email: Komar@amp.edu.pl

    >